Dr. James Thomas Loynes, MD

Dr. Loynes practices at Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation.

Dr. Loynes' NPI, 1386691855, was assigned on May 28, 2006. Dr. Loynes graduated from Medical University of South Carolina College of Medicine in 1997. Dr. Loynes holds Virginia license 0101234459.

Dr. Loynes' primary practice is Cleveland Clinic Akron General, at 1 Akron General Avenue, Akron, OH 44307 in Summit County. The practice phone is (330) 344-6000.

Dr. Loynes' primary practice is Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation. Dr. Loynes is also affiliated with Novant Health New Hanover Regional Medical Center. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Loynes to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Loynes practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Loynes' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Loynes is licensed in Virginia.

CMS data shows 1,029 Medicare services from Dr. Loynes across 7 procedure codes in 2024, for 443 Medicare patients. Medicare paid $82,477 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 443 Medicare patients who saw Dr. Loynes in 2024. The largest group is 75 to 84, with 204 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Loynes' median patient age at 65, with 58% women.

In 2024, Dr. Loynes wrote 630 Medicare Part D claims for 192 patients. 87% of them were for generic drugs. CMS names the drug for 382 of them, across 12 drugs with 11 or more claims each, at $400,330 in total drug cost. In 2023, CMS named 547 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 74 out of 100 for Dr. Loynes for performance year 2024, reported individually. Dr. Loynes accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 31 general payments to Dr. Loynes from 17 drug and device companies from 2016 to 2025. Education make up the largest share, 68% of the total. Incyte Corporation paid the most, $320.

Dr. Loynes graduated from Medical University of South Carolina College of Medicine in 1997.